MSME (Udyam registered) Ministry of MSME
- Category
- Small (2022-23)
- Udyam number
- UDYAM-TS-02-0000510
Vanguard Therapeutics Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹18.98 Cr
▼ 19% YoY
Net profit · FY 2025
₹1.87 Cr
Net margin 9.9%
EBITDA · FY 2025
₹3.01 Cr
EBITDA margin 15.9%
Authorised capital
₹15 Cr
Registered with MCA
Paid-up capital
₹7.66 Cr
Issued & subscribed
Open charges
₹81.56 Lakh
Satisfied ₹14.65 Cr
Company age
40 yrs
Est. 1986
Employees · EPFO
2
Provident fund records
About Vanguard Therapeutics Private Limited
Data last updated:
Vanguard Therapeutics Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 April 1986 and has been in existence for over 40 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U70102TG1986PTC006360. Its GSTIN is 36AABCV3173H1ZB (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹15 Cr and a paid-up capital of ₹7.66 Cr. It is led by directors including Potineni Koteswara Rao (Managing Director) and Potineni Swetha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 17 3Rt 3rd Floor Opp.Andhrabank Lane S.R.Nagar Hyderabad, Telangana, India – 500038.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.98 Cr, a decline of 19% compared to the previous year. For the same year it recorded a net profit of ₹1.87 Cr (net margin 9.9%) and EBITDA of ₹3.01 Cr (EBITDA margin 15.9%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years.
The company has about 2 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹81.56 Lakh and satisfied charges of ₹14.65 Cr on record. Court records list 20 cases involving the company, including 6 filed by the company and 14 filed against it; 7 cases are pending. The company has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹26.73 Cr; the latest was in March 2016. Its 5 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 3 smaller; the largest is Maha Avtar Health Care Private Limited with revenue of ₹19.06 Cr.
Vanguard Therapeutics Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0000510). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vanguardgroup.in.
Company details
CIN U70102TG1986PTC006360
Registration Number 006360
Incorporation Date 07 April 1986
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-02-0000510
CIN history
Vanguard Therapeutics has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U70102TG1986PTC006360, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U70102TG1986PTC006360 | Current |
| U33311AP1986PTC006360 | Previous |
| U70102AP1986PTC006360 | Previous |
Key People
Potineni Koteswara Rao Managing Director Potineni Swetha Director Potineni Vindhya Rani Director Recognitions & Rankings of Vanguard Therapeutics
Contact details
Vanguard Therapeutics Private Limited's registered office is in Hyderabad, Telangana. Its website is vanguardgroup.in. Its e-mail address is in the company report.
- Email
- Website
- Registered Address17 3Rt 3rd Floor Opp.Andhrabank Lane S.R.Nagar Hyderabad, Telangana, India – 500038
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Vanguard Therapeutics Private Limited, buy the company report.
Comprehensive company report
Vanguard Therapeutics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Vanguard Therapeutics is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Vanguard Therapeutics Private Limited, buy the company report.
Financials of Vanguard Therapeutics Private Limited
FY 2025 filings availableVanguard Therapeutics Private Limited reported revenue of ₹18.98 Cr (down 19% YoY) for FY 2025.
Revenue · FY 2025
₹18.98 Cr ▼ 19%
Net profit · FY 2025
₹1.87 Cr margin 9.9%
EBITDA · FY 2025
₹3.01 Cr margin 15.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 19%
3 years · compounded
▼ 2%
EBITDA CAGR growth
1 year
▼ 12%
5 years · compounded
▲ 16%
Revenue has declined at a compounded annual rate (CAGR) of 2% over three years, including a 19% fall in the latest year. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.01 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.87 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.9% | ||||
| Net Profit Margin | 9.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vanguard Therapeutics Private Limited, buy the company report.
Board of directors of Vanguard Therapeutics Private Limited
Vanguard Therapeutics has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Potineni Swetha Also directs: Veeraasva Equestrian LLP | Director | 01 Aug 2022 | 4 Years 3 Months | Current |
| Potineni Koteswara Rao | Managing Director | 07 Apr 1986 | 40 Years 6 Months | Current |
| Potineni Vindhya Rani | Director | 05 Feb 1991 | 35 Years 9 Months | Current |
Peer comparison
Vanguard Therapeutics Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Maha Avtar Health Care Private Limited | ₹19.06 Cr (FY 2025) | 43.0% | Delhi, India | |||
| I G Pharma Limited | ₹18.98 Cr (FY 2025) | 7.0% | Roorkee, Uttarakhand, India | |||
| Vanguard Therapeutics Private Limitedthis company | ₹18.98 Cr (FY 2025) | ₹1.87 Cr | 9.9% | -19.0% | 2 | Hyderabad, Telangana, India |
| Vasudha Life Science Private Limited | ₹18.95 Cr (FY 2025) | 27.0% | Brahmavara, Karnataka, India | |||
| Isera Biological Limited | ₹18.94 Cr (FY 2025) | 83.0% | Pune, Maharashtra, India | |||
| Kee Pharma Limited | ₹18.89 Cr (FY 2025) | 3.0% | New Delhi, Delhi, India |
To see the full peer comparison of Vanguard Therapeutics Private Limited, buy the company report.
Auditor
Vanguard Therapeutics Private Limited is audited by A.S.R.V. PRASAD & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A.S.R.V. PRASAD & CO | FY 2023 | 009983S |
Shareholding
The shareholding of Vanguard Therapeutics Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vanguard Therapeutics Private Limited, buy the company report.
Charges & borrowings
Open charges
₹81.56 Lakh
Satisfied charges
₹14.65 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Dec 2024 | 101034520 | Hdfc Bank Limited | ₹81.56 Lakh | Open | |
| 30 Nov 2013 | 10462933 | Hdfc Bank Limited | ₹4.95 Cr | Satisfied | |
| 07 Feb 2008 | 10097280 | 3I Infotech Trusteeship Services Limited | ₹5 Cr | Satisfied | |
| 31 Dec 2004 | 90138516 | Icici Bank Ltd | ₹3.75 Cr | Satisfied | |
| 02 Mar 2002 | 90138336 | The Karnataka Bank Ltd | ₹15 Lakh | Satisfied |
To see the full charge records of Vanguard Therapeutics Private Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
Vanguard Therapeutics Private Limited has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹26.73 Cr; the latest was in March 2016.
Total deals
5
Funding rounds
3
Secondary share transfers
2
Disclosed funding
₹26.73 Cr
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Mar 2013 | Funding round | ₹22.46 Cr | Investors: 4 individuals |
| Mar 2010 | Funding round | ₹1.15 Cr | Investors: 4 individuals |
| Dec 2008 | Funding round | ₹3.12 Cr | Investors: 4 individuals |
| Sep 2006 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Vanguard Therapeutics Private Limited has 20 court cases on record: 6 filed by Vanguard Therapeutics, 14 filed against it. 7 cases are pending and 13 are disposed.
Total cases
20
Filed by the company
6
Filed against the company
14
Pending
7
Disposed
13
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 15 | 12 | 3 |
| High courts | 5 | 2 | 4 |
Cases on record (5 of 20)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Rangareddy, Telangana | Civil suit | Filed by the company against M/S. Fizikem Laboratories Private Limited | Pending |
| District court, West, Delhi | Civil suit | Filed against the company by Om Logistics Ltd | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed against the company by Scott Edil Pharmacia Ltd | Disposed |
| District court, Rangareddy, Telangana | Criminal complaint | Filed against the company by State of Telangana, Drugs Inspector | Pending |
| District court, Rangareddy, Telangana | Civil suit | Filed by the company against individuals | Pending |
To see the full case history of Vanguard Therapeutics Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vanguard Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Vanguard Therapeutics Private Limited has a workforce of 2 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
Employee count
2
Active EPFO establishments
1
GST
Vanguard Therapeutics has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCV3173H1ZB | Telangana | Active | 01 Jul 2017 |
| 37AABCV3173H1Z9 | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vanguard Therapeutics Private Limited, buy the company report.
Recent activity
Vanguard Therapeutics Private Limited has 6 board changes on record since 1986: 3 appointments and 3 cessations. The latest: Potineni Swetha was appointed as Director on 01 Aug 2022.
AGM
Vanguard Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Vanguard Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.82 Cr with Charge ID 101034520 was registered on 11 Dec 2024.
Appointed
Potineni Swetha was appointed as Director.
Charges
A charge registered on 30 Nov 2013 via Charge ID 10462933 with Hdfc Bank Limited was fully satisfied on 28 Sep 2021.
Charges
A charge with Hdfc Bank Limited of Rs. 4.95 Cr registered on 30 Nov 2013 with Charge ID 10462933 was modified on 23 Dec 2020.
Charges
A charge registered on 07 Feb 2008 via Charge ID 10097280 with 3I Infotech Trusteeship Services Limited was fully satisfied on 03 Jan 2014.
Charges
A charge registered on 31 Dec 2004 via Charge ID 90138516 with Icici Bank Ltd was fully satisfied on 03 Jan 2014.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 4.95 Cr with Charge ID 10462933 was registered on 30 Nov 2013.
Charges
A charge registered on 02 Mar 2002 via Charge ID 90138336 with The Karnataka Bank Ltd was fully satisfied on 27 Aug 2012.
Charges
A charge registered on 15 Sep 1998 via Charge ID 90138069 with Karnataka Bank Ltd was fully satisfied on 27 Aug 2012.
Charges
A charge registered on 01 Dec 1995 via Charge ID 90137797 with Karnataka Bank Ltd was fully satisfied on 27 Aug 2012.
13 earlier events are in the company report.
Frequently asked questions
Vanguard Therapeutics is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 April 1986 (40+ years old) and is registered under CIN U70102TG1986PTC006360.
Vanguard Therapeutics has 3 current directors:
- Potineni Koteswara Rao - Managing Director
- Potineni Swetha - Director
- Potineni Vindhya Rani - Director
The latest financial statements of Vanguard Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Vanguard Therapeutics is 36AABCV3173H1ZB, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AABCV3173H1Z9 (Andhra Pradesh).
The CIN (Corporate Identification Number) of Vanguard Therapeutics is U70102TG1986PTC006360. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vanguard Therapeutics has 20 court cases on record: 6 filed by the company and 14 filed against it. 7 are pending. Most are in the district courts.
Vanguard Therapeutics was incorporated on 07 April 1986, making it 40+ years old. It is registered with the Registrar of Companies, Hyderabad.
Vanguard Therapeutics has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹26.73 Cr; the latest was in March 2016.
The peers of Vanguard Therapeutics by revenue are Maha Avtar Health Care Private Limited, I G Pharma Limited, Vasudha Life Science Private Limited, Isera Biological Limited, Kee Pharma Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Potineni Swetha was appointed as Director on 01 Aug 2022. Potineni Swetha ceased to be Director on 30 Apr 2012. Muppa Ashok Vardhan ceased to be Director on 06 Apr 2009. Vanguard Therapeutics has 6 board changes on record in total.
Yes, Vanguard Therapeutics is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0000510).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages